Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
- Ok, Chi Young
- Xu-Monette, Zijun Y
- Tzankov, Alexandar
- O'Malley, Dennis P
- Montes-Moreno, Santiago
- Visco, Carlo
- Møller, Michael B
- Dybkaer, Karen
- Orazi, Attilio
- Zu, Youli
- Bhagat, Govind
- Richards, Kristy L
- Hsi, Eric D
- Han van Krieken, J
- Ponzoni, Maurilio
- Farnen, John P
- Piris, Miguel A
- Winter, Jane N
- Medeiros, L Jeffrey
- Young, Ken H
DOIAbstract
Cyclin D1 expression has been reported in a subset of patients with diffuse large B-cell leukemia (DLBCL), but studies have been few and generally small, and they have demonstrated no obvious clinical implications attributable to cyclin D1 expression
Add to ORKG